MXPA02005011A - Nuevos derivados de tiazolidindiona como agentes antidiabeticos. - Google Patents

Nuevos derivados de tiazolidindiona como agentes antidiabeticos.

Info

Publication number
MXPA02005011A
MXPA02005011A MXPA02005011A MXPA02005011A MXPA02005011A MX PA02005011 A MXPA02005011 A MX PA02005011A MX PA02005011 A MXPA02005011 A MX PA02005011A MX PA02005011 A MXPA02005011 A MX PA02005011A MX PA02005011 A MXPA02005011 A MX PA02005011A
Authority
MX
Mexico
Prior art keywords
antidiabetic agents
thiazolidinedione derivatives
novel thiazolidinedione
novel
derivatives
Prior art date
Application number
MXPA02005011A
Other languages
English (en)
Inventor
Marisabel Mourelle Mancini
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Publication of MXPA02005011A publication Critical patent/MXPA02005011A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MXPA02005011A 1999-11-18 2000-11-15 Nuevos derivados de tiazolidindiona como agentes antidiabeticos. MXPA02005011A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902533A ES2156574B1 (es) 1999-11-18 1999-11-18 Nuevos derivados de tiazolidindiona como agentes antidiabeticos
PCT/ES2000/000432 WO2001036416A1 (es) 1999-11-18 2000-11-15 Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Publications (1)

Publication Number Publication Date
MXPA02005011A true MXPA02005011A (es) 2003-10-14

Family

ID=8310628

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02005011A MXPA02005011A (es) 1999-11-18 2000-11-15 Nuevos derivados de tiazolidindiona como agentes antidiabeticos.

Country Status (37)

Country Link
US (1) US7001910B1 (es)
EP (1) EP1231211B1 (es)
JP (1) JP2003514817A (es)
KR (1) KR100518110B1 (es)
CN (1) CN1159314C (es)
AP (1) AP1330A (es)
AR (1) AR031080A1 (es)
AT (1) ATE241622T1 (es)
AU (1) AU770045B2 (es)
BG (1) BG106699A (es)
BR (1) BR0015613A (es)
CA (1) CA2391913A1 (es)
CO (1) CO5261560A1 (es)
CR (1) CR6640A (es)
CZ (1) CZ20021654A3 (es)
DE (1) DE60003072T2 (es)
DK (1) DK1231211T3 (es)
EA (1) EA004301B1 (es)
EE (1) EE200200254A (es)
ES (2) ES2156574B1 (es)
GE (1) GEP20043240B (es)
HR (1) HRP20020426A2 (es)
HU (1) HUP0203478A2 (es)
IL (1) IL149634A0 (es)
IS (1) IS2014B (es)
MA (1) MA26844A1 (es)
MX (1) MXPA02005011A (es)
NO (2) NO20022336L (es)
NZ (1) NZ519264A (es)
OA (1) OA12089A (es)
PE (1) PE20010858A1 (es)
PL (1) PL354877A1 (es)
PT (1) PT1231211E (es)
SK (1) SK6752002A3 (es)
WO (1) WO2001036416A1 (es)
YU (1) YU40202A (es)
ZA (1) ZA200203906B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174748B1 (es) * 2001-01-31 2003-09-16 Vita Lab Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
US7713983B2 (en) 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CL2004000409A1 (es) 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US20050014732A1 (en) * 2003-03-14 2005-01-20 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-diabetic agent
US7928107B2 (en) 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8283354B2 (en) 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
JP5546372B2 (ja) * 2010-06-30 2014-07-09 積水メディカル株式会社 ベンジルヒダントイン化合物の製造法
WO2016184895A1 (en) 2015-05-18 2016-11-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Means for detecting or measuring a biological activity of a botulinum toxin
US10689374B1 (en) 2019-07-12 2020-06-23 United Arab Emirates University Pyrimidine-thiazolidinone derivatives
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
ES2156574B1 (es) 2002-02-01
WO2001036416A1 (es) 2001-05-25
ATE241622T1 (de) 2003-06-15
AP1330A (en) 2004-11-25
NO20022336D0 (no) 2002-05-15
EA004301B1 (ru) 2004-02-26
AU770045B2 (en) 2004-02-12
IL149634A0 (en) 2002-11-10
ES2199878T3 (es) 2004-03-01
BR0015613A (pt) 2002-07-23
AP2002002512A0 (en) 2002-06-30
CR6640A (es) 2004-03-05
BG106699A (bg) 2003-02-28
NZ519264A (en) 2003-10-31
KR20020079737A (ko) 2002-10-19
CN1402724A (zh) 2003-03-12
GEP20043240B (en) 2004-05-25
EA200200470A1 (ru) 2002-10-31
KR100518110B1 (ko) 2005-10-04
DE60003072T2 (de) 2004-04-01
CN1159314C (zh) 2004-07-28
IS2014B (is) 2005-06-15
CA2391913A1 (en) 2001-05-25
ZA200203906B (en) 2004-03-26
OA12089A (en) 2006-05-04
MA26844A1 (fr) 2004-12-20
PE20010858A1 (es) 2001-08-22
US7001910B1 (en) 2006-02-21
JP2003514817A (ja) 2003-04-22
NO20022336L (no) 2002-07-09
ES2156574A1 (es) 2001-06-16
NO20022379D0 (no) 2002-05-16
YU40202A (sh) 2006-01-16
AR031080A1 (es) 2003-09-10
DK1231211T3 (da) 2003-10-27
CO5261560A1 (es) 2003-03-31
PT1231211E (pt) 2003-09-30
SK6752002A3 (en) 2002-09-10
EP1231211A1 (en) 2002-08-14
EE200200254A (et) 2003-06-16
AU1281501A (en) 2001-05-30
EP1231211B1 (en) 2003-05-28
HRP20020426A2 (en) 2004-02-29
IS6386A (is) 2002-05-15
CZ20021654A3 (cs) 2002-09-11
PL354877A1 (en) 2004-03-08
DE60003072D1 (de) 2003-07-03
HUP0203478A2 (hu) 2003-02-28

Similar Documents

Publication Publication Date Title
ZA200204283B (en) Novel antidiabetic agents.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
IL149841A0 (en) Novel benzomidazole derivatives useful as antiproliferative agents
ZA200203003B (en) N-substituted carbamoyloxyalkyl-azolium derivatives.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
IL146110A0 (en) Thiazolidinedione derivative and its use as antidiabetic
ZA9811925B (en) Thiazole derivatives.
ZA200108718B (en) Thiazolidinedione derivative and its use as antidiabetic.
MXPA02005011A (es) Nuevos derivados de tiazolidindiona como agentes antidiabeticos.
MXPA00011504A (es) Derivados heterociclicos sustituidos.
HK1045151A1 (en) Thiazolidinedione derivative and its use as antidiabetic.
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
HK1045304A1 (en) Thiazolidinedione derivative and its use as antidiabetic.
ZA200204492B (en) Heterocyclic derivatives.
MXPA01011285A (es) Derivados de tio-oxindol.
AU7961800A (en) Thiazolidinedione derivatives
ZA9811923B (en) Thiazole derivatives.
SI1231211T1 (en) Thiazolidinedione derivatives as antidiabetic agents
GB2353794B (en) Deadplate assembly for I.S. machine
EP1175403A4 (en) 6,7-DISUBSTITUEE-5,8-QUINOLEINEDIONE DERIVATIVES AS ANTIFUNGAL AGENTS
AU5414400A (en) 1,4-diazacycloheptane derivatives as neuroprotective agents
ZA200201714B (en) Novel compound F-15078.
GB2350361B (en) 3,4,5-tricyanophenyl derivatives

Legal Events

Date Code Title Description
GB Transfer or rights
FG Grant or registration